Gerresheimer AG

Gerresheimer AG: Adjustment of growth guidance for 2024 and 2025

Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group / Moulded Glass business to be strategically reviewed

Gerresheimer AG: Gerresheimer AG issues 3,140,000 million new shares at a placement price of EUR 86.50 per new share

Gerresheimer AG: Gerresheimer AG launches cash capital increase with exclusion of shareholders’ subscription rights through accelerated bookbuilding by up to 3,140,000 shares

Gerresheimer acquires Sensile Medical / irrespective of that, increased growth and improved profitability expected mid-term due to two new major orders with temporarily higher capex / organic revenue guidance 2018 narrowed to upper end of range

Gerresheimer AG: Dr. Christian Fischer resigns as CEO of Gerresheimer AG